| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| (loss) income before income tax benefit (expense) | -23,074 | -71,052 | 929,828 | -97,991 |
| Income tax benefit (expense) | -38,970 | -6,203 | 63,266 | 8,663 |
| Net income (loss) attributable to common stockholders | 15,896 | -64,849 | 866,562 | -106,654 |
| Earnings per share, basic | 0.2 | -0.83 | 11.09 | -1.39 |
| Earnings per share, diluted | 0.2 | -0.83 | 10.04 | -1.39 |
| Weighted average number of shares outstanding, basic | 78,471,119 | 78,151,240 | 78,115,836 | 76,925,523 |
| Weighted average number of shares outstanding, diluted | 87,115,369 | 78,151,240 | 86,385,922 | 76,925,523 |
PTC THERAPEUTICS, INC. (PTCT)
PTC THERAPEUTICS, INC. (PTCT)